about
Analysis of mercury-induced immune activation in nonobese diabetic (NOD) miceThe role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host diseaseTissue distribution of 35S-labelled perfluorobutanesulfonic acid in adult mice following dietary exposure for 1-5 days.Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line.Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.Mercury-induced anti-nucleolar autoantibodies can transgress the membrane of living cells in vivo and in vitro.Hematologic malignancies in elderly patients.Tissue distribution of ³⁵S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose.Dietary exposure to perfluorooctanoate or perfluorooctane sulfonate induces hypertrophy in centrilobular hepatocytes and alters the hepatic immune status in mice.Spontaneous downregulation of antibody/autoantibody synthesis in susceptible mice upon chronic exposure to mercuric chloride is not owing to a general immunosuppression.Mercuric chloride induces a strong immune activation, but does not accelerate the development of dermal fibrosis in tight skin 1 mice.The nanoparticulate Quillaja saponin KGI exerts anti-proliferative effects by down-regulation of cell cycle molecules in U937 and HL-60 human leukemia cells.Evaluation of interleukin 12 and CD56+ lymphocyte cells in pediatric hematopoietic stem cell transplantation for early diagnosis of acute graft versus host disease.High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in aGVHD after chemotherapy conditioning in allogeneic transplanted mice.Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice.The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway.Mathematical modeling of tumor-induced immunosuppression by myeloid-derived suppressor cells: Implications for therapeutic targeting strategies.Cytochrome P450 2J2, a new key enzyme in cyclophosphamide bioactivation and a potential biomarker for hematological malignancies.Rapid and Robust Quantification of p-Xyleneselenocyanate in Plasma via Derivatization.Characterization of the hepatic and splenic immune status and immunoglobulin synthesis in aged male mice lacking the peroxisome proliferator-activated receptor-alpha (PPARα).Efficient gene transfer into primary human natural killer cells by retroviral transduction.Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis.Xenobiotic metal-induced autoimmunity: mercury and silver differentially induce antinucleolar autoantibody production in susceptible H-2s, H-2q and H-2f mice.Genetic control of resistance to mercury-induced immune/autoimmune activation.Downregulation of miR-1266-5P, miR-185-5P and miR-30c-2 in prostatic cancer tissue and cell lines.Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imagingComplement activation is involved in the hepatic injury caused by high-dose exposure of mice to perfluorooctanoic acidExposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 miceSimultaneous formulation of influenza vaccine and chitosan nanoparticles within CpG oligodesoxi nucleotides leads to dose-sparing and protects against lethal challenge in the mouse modelHuman IgG rheumatoid factors and RF-like immune complexes induce IgG1 rheumatoid factor production in miceLongevity of immune complexes and abnormal germinal centre formation in NZB miceImmune complex-induced chronic and intense IL-4 independent IgG1-rheumatoid factor production in NZB miceMercury-induced renal immune complex deposits in young (NZB x NZW)F1 mice: characterization of antibodies/autoantibodiesMechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involvedThe atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha
P50
Q28347459-5607252A-DD8E-42D7-8EA7-3BCE7CE917C0Q34673038-EDD32152-BF22-4BBD-8EFC-7DBB1BF711E8Q35044687-BF37C25C-817D-4CCC-AB50-C59E68EAF4F9Q37505854-DA722877-6B53-43BA-A42D-5067D6D55BF3Q37517571-BD4D7CC8-C3F7-46E1-A3F3-C936F0E9BB9CQ38748866-29DCD883-EDF9-41F4-898D-FF80FC577508Q38869871-36506846-9A98-40E5-B30B-703F97CC2482Q40493217-F6886ABD-492E-48C4-8F2A-87C8E1DAE803Q40954865-D10F1AA1-80B2-47B9-8F30-3C022C15DD9AQ42716194-9AC70D78-6189-4C80-B396-9D1F8A83AB1FQ42744243-8F96C515-858E-4576-A710-7DC3E1B894E7Q42917695-C7F8589E-1FF9-4328-B7C9-DFC7938F8AF4Q43970939-D9ABFD2F-D3CF-4D05-BA50-D6ACA3FCDC4AQ44893847-08435A50-8492-434B-93FD-9C4FD2D5934FQ45059085-9882A29E-D742-4903-9972-A513A3026549Q45859255-EDA74251-4ACE-4C3D-ACB4-0F83A701E91FQ45961355-8E6E81DC-C63B-40D2-BFCC-27E0191F5B36Q46344148-F6CBDD35-729F-4EA2-8B05-A5E2C717414BQ46582028-EFEB8FF3-627F-4F05-9FB4-A8C5DB4E2DEBQ46788556-F6313356-A82C-4EAB-BBF8-96F7AC976B64Q47116870-2C32C808-1629-49D7-989A-ACB58A5FF8D8Q47562876-45BBB39C-AE04-4B16-B064-0B22217EDF6BQ48234194-DAFA337D-4A48-4D9E-84D8-7BC9D67A672FQ48236740-691F8138-37B5-40D3-88FD-5B6A88D8B8B8Q50549589-EC60B8B1-DE2C-4130-9345-CF8523BB320CQ50748854-D924E952-5841-427A-A80D-2A869D988F21Q52948275-D55037C8-6083-49CB-A836-E4C43DFFF02AQ53939717-09041EA6-D91A-46DE-A0CB-1FB2AE6408F2Q54002929-5D4DFBE3-6004-4F1A-84A0-287561089D32Q55115788-3F7A3F6C-2D92-4E82-AA31-616FD0860E58Q57350128-B9AA5964-F5AF-4C46-9E52-961632933B47Q58788838-7E67BEFD-77D4-429C-98BF-DCE24D3CB37BQ58789247-1320A1F5-9C0C-4AA6-85E3-CBF8EC77CDCAQ59353257-8BB5CEEB-B5E5-4F99-A732-57EF69600C7EQ72287352-519F0976-49E5-440C-8B0B-24D6D90B148CQ73302535-F5922313-CB40-4062-8BFA-E51780EBDE60Q73420211-CE69543C-3F44-42DC-AF80-347BA32E5A50Q73835997-0E62D896-E3CD-42F7-B82A-07D6AC6BBC7DQ77419245-8935CF76-AEED-40CC-8A77-4DA02C959EF5Q83891688-1AF99700-9872-4965-8414-4BBFD097ADB0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Manuchehr Abedi-Valugerdi
@ast
Manuchehr Abedi-Valugerdi
@en
Manuchehr Abedi-Valugerdi
@es
Manuchehr Abedi-Valugerdi
@nl
type
label
Manuchehr Abedi-Valugerdi
@ast
Manuchehr Abedi-Valugerdi
@en
Manuchehr Abedi-Valugerdi
@es
Manuchehr Abedi-Valugerdi
@nl
prefLabel
Manuchehr Abedi-Valugerdi
@ast
Manuchehr Abedi-Valugerdi
@en
Manuchehr Abedi-Valugerdi
@es
Manuchehr Abedi-Valugerdi
@nl
P106
P31
P496
0000-0002-4122-2879